Notably, four C-oncogenes (NOTH1, FGFR2 and MYC for the breast cancer and FGFR3 for the colorectal cancer) were found to be amplified but down-regulated in their corresponding cancer types. This evidence concerns the gene FGFR2 and breast carcinoma.